Strides, STADA plan drug for US

Strides Arcolab Ltd's, US subsidiary Strides Inc and STADA Pharmaceuticals Inc, the US subsidiary of STADA Arzneimittel AG, have signed a development and supply agreement for a prescription generic drug product for the US market.

The product will be developed and manufactured by Strides Inc at its US soft gelatin manufacturing facility exclusively for STADA's sale in the US, Stride informed the Bombay Stock Exchange on Thursday.